| 000 | 00982cas a22002893c 4500 | ||
|---|---|---|---|
| 999 |
_c341885 _d341885 _x1 |
||
| 001 | 341885 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230102115954.0 | ||
| 006 | s||||oo ||| 0 0 | ||
| 007 | cr c| |||||||| | ||
| 008 | 190206c20109999gw || poo 0 0eng d | ||
| 022 | _a2042-0994 | ||
| 040 |
_bspa _cES-MaUEC _dES-MaUEC |
||
| 050 | 4 |
_aRM302.5 _bES |
|
| 245 | 0 | 0 | _aTherapeutic Advances in Drug Safety |
| 264 | 1 |
_aCalifornia _bSage Publications _c2010- |
|
| 300 | _a1 recurso en línea | ||
| 336 |
_2rdacontent _aTexto _btxt |
||
| 337 |
_2rdamedia _aelectrónico _bc |
||
| 338 |
_2rdacarrier _arecurso electrónico _bcr |
||
| 988 | _aSAGE Premier | ||
| 650 | 7 |
_2embne _9679502 _aFarmacoepidemiología _vPublicaciones periódicas |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://journals.sagepub.com/loi/TAW _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 866 | 0 | _a2010- | |
| 942 |
_2lcc _cRE _n0 |
||
| 998 |
_b09/2021 _dr _eh _zSI |
||